Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review - Takeaways - MDSpire

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review

  • By

  • Ekaterina Laukhtina

  • Reza Sari Motlagh

  • Keiichiro Mori

  • Fahad Quhal

  • Victor M. Schuettfort

  • Hadi Mostafaei

  • Satoshi Katayama

  • Nico C. Grossmann

  • Guillaume Ploussard

  • Pierre I. Karakiewicz

  • Alberto Briganti

  • Mohammad Abufaraj

  • Dmitry Enikeev

  • Benjamin Pradere

  • Shahrokh F. Shariat

  • May 28, 2021

  • 0 min

Share

  • 1

    Delays in radical prostatectomy (RP) during the COVID-19 pandemic significantly reduced the number of procedures performed.

  • 2

    Prolonged treatment delays in intermediate- and high-risk prostate cancer may lead to disease progression and adverse outcomes.

  • 3

    This systematic review aimed to evaluate the oncologic impact of deferred RP in men with intermediate- and high-risk prostate cancer.

  • 4

    Nineteen studies were included in the review, highlighting significant heterogeneity in definitions of RP delays.

  • 5

    The review found no high-level evidence indicating that a delay of up to 3 months significantly impacts oncological outcomes.

Original Source(s)

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review

  • by Ekaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, Fahad Quhal, Victor M. Schuettfort, Hadi Mostafaei, Satoshi Katayama, Nico C. Grossmann, Guillaume Ploussard, Pierre I. Karakiewicz, Alberto Briganti, Mohammad Abufaraj, Dmitry Enikeev, Benjamin Pradere, Shahrokh F. Shariat

  • May 28, 2021

Related Content

Anatomical, functional, and patient-reported outcomes following anterior urethroplasty. Can we predict when and why are patients with anatomical recurrences requiring reinterventions?

Single-port robotic-assisted radical prostatectomy: evaluating the Da Vinci SP system in minimally invasive urologic oncology

Post-surgical outcomes in transgender women: a prospective analysis of sexual function and health-related quality of life